Related by context. All words. (Click for frequent words.) 66 thromboembolic events 65 restenosis 65 TAXUS 64 thrombotic events 64 Stent thrombosis 63 definite stent thrombosis 63 repeat revascularization 62 reinfarction 62 ipsilateral stroke 62 drug eluting stents 62 thromboembolism 61 stent thromboses 61 venous thromboembolism 61 stenting 61 TAXUS Stent 60 myocardial infarction 60 CYPHER ® Stent 60 cardiovascular hospitalization 59 TAXUS stent 59 acute coronary syndrome 59 cerebrovascular events 59 myocardial infarctions 59 dual antiplatelet therapy 59 target lesion revascularization 59 myocardial infarction MI 58 binary restenosis 58 carotid stenting 58 cryptogenic stroke 58 thrombosis 58 clopidogrel 58 MACCE 58 VT VF 57 ticagrelor 57 nonfatal MI 57 enoxaparin 57 sirolimus eluting stents 57 CYPHER R Stent 57 ximelagatran 57 periprocedural 57 target vessel revascularization 57 revascularization 57 sirolimus eluting stent 56 Taxus Stent 56 ST elevation myocardial 56 Events MACE 56 fondaparinux 56 thromboembolic 56 XIENCE V vs. 56 STEMI 56 endarterectomy 56 cardiovascular hospitalizations 56 reintervention 56 VTE 56 TAXUS Express Stent 56 myocardial infarction stroke 56 eptifibatide 56 Major Adverse Cardiac 55 TAVI 55 nonfatal myocardial infarction 55 perioperative mortality 55 rehospitalization 55 MIs 55 cardiovascular mortality 55 XIENCE V PROMUS Stent 55 amiodarone 55 thrombotic complications 55 drug eluting stent 55 nesiritide 55 carotid endarterectomy 55 recurrent ischemia 55 recurrent VTE 55 tumor recurrence 55 atherothrombotic events 55 zotarolimus eluting stent 55 dronedarone 55 LVEF 55 tirofiban 55 symptomatic VTE 55 XIENCE V demonstrated 55 revascularisation 55 rivaroxaban 55 stent implantation 55 noninferiority 55 hyperkalemia 54 virologic failure 54 TAXUS p value 54 paroxysmal AF 54 STEMI patients 54 arterial thromboembolic events 54 aortic stenosis 54 paclitaxel eluting stent 54 cardiotoxicity 54 rebleeding 54 acute myocardial infarction AMI 54 hemorrhagic complications 54 coronary revascularization 54 angiographic restenosis 54 infarction STEMI 54 stent restenosis 54 rosuvastatin 54 reoperation 54 bivalirudin 54 antiplatelet therapy 53 percutaneous coronary intervention 53 contrast induced nephropathy 53 mm Stent 53 PFO closure 53 discontinuations 53 vertebral fractures 53 upper gastrointestinal bleeding 53 revascularizations 53 Endeavor stent 53 CYPHER Stent 53 carotid artery stenting 53 endoleaks 53 statin therapy 53 cardiac toxicity 53 beta blocker therapy 53 atrial fibrillation AF 53 revascularization procedures 53 fatal myocardial infarction 53 atrial fibrillation 53 reblockage 53 thromboses 52 cardiogenic shock 52 periprocedural MI 52 DAPT 52 rosiglitazone 52 QTc 52 telmisartan 52 carotid stenosis 52 severe hypoglycemia 52 ARCOXIA 52 CABG 52 microalbuminuria 52 events MACE 52 resuscitated cardiac arrest 52 infarct size 52 endophthalmitis 52 RE LY 52 everolimus eluting stents 52 paclitaxel eluting stents 52 sirolimus stent 52 ADHF 52 pericardial effusion 52 acute coronary syndromes 52 perioperative complications 52 cardiovascular ischemic 52 intracerebral hemorrhage 52 adalimumab 52 virologic response 52 antithrombotic therapy 52 stable angina 52 composite endpoint 52 ischemic 52 infarctions 52 stenoses 52 valvulopathy 52 locoregional recurrence 52 postoperative mortality 52 CRBSI 52 febrile neutropenia 52 nonfatal stroke 52 sudden cardiac death 52 vertebral fracture 52 recurrent myocardial infarction 52 COPD exacerbations 52 coronary artery disease 52 IIIa inhibitor 52 Target Lesion Revascularization TLR 52 hepatotoxicity 52 hypoglycemia 52 abciximab 52 stent placement 52 stenosis 52 postoperative complications 52 DVT PE 52 ranolazine 51 Restenosis 51 unstable angina pectoris 51 aprotinin 51 neointimal hyperplasia 51 bevacizumab 51 ischemic cardiomyopathy 51 venous thrombosis 51 NYHA class 51 myocardial ischemia 51 prasugrel 51 atherothrombotic disease 51 anticoagulation 51 unfractionated heparin 51 cerebral vasospasm 51 ICD implantation 51 CYPHER ® 51 left ventricular dysfunction 51 severe hypoglycemic 51 nonrandomized 51 discontinuations due 51 coronary intervention 51 thrombolytic therapy 51 systemic embolism 51 non valvular atrial 51 onset sepsis 51 prolonged QT interval 51 Acute Coronary Syndrome 51 percutaneous intervention 51 bradycardia 51 TEAEs 51 intraventricular hemorrhage 51 gout flares 51 candesartan 51 apixaban 51 stent 51 HF hospitalization 51 unstable angina 51 platelet reactivity 51 postoperative atrial fibrillation 51 microvascular complications 51 SYNTAX 51 macrovascular events 51 SORT OUT III 51 cardiac resynchronization 51 valsartan 51 angiographic 51 paroxysmal atrial fibrillation 51 TAXUS Liberte Long 51 ischemia driven 51 acute myocardial infarction 50 QTc prolongation 50 DES implantation 50 venous thromboembolic events 50 Fonarow 50 ventricular arrhythmias 50 tiotropium 50 everolimus eluting stent 50 CMV disease 50 CABG surgery 50 malapposition 50 NYHA Class II 50 subclinical hypothyroidism 50 STRIDE PD 50 silent ischemia 50 thrombolysis 50 TAXUS Express 50 renal dysfunction 50 hemodynamic instability 50 ventricular tachyarrhythmias 50 preterm deliveries 50 pioglitazone 50 unstable angina UA 50 TIMI 50 acute coronary syndromes ACS 50 XIENCE V 50 ezetimibe simvastatin 50 MitraClip 50 preterm infants 50 tolvaptan 50 Endarterectomy 50 thrombolytic agents 50 LV dysfunction 50 colorectal adenoma 50 NSTE ACS 50 thromboembolic complications 50 ischemic stroke 50 MADIT II 50 eplerenone 50 postoperative complication 50 NEVO ™ 50 ventricular tachycardia 50 CYPHER R Sirolimus eluting 50 ATACAND 50 cardiac dysfunction 50 FOLFOX4 50 inhospital 50 TAXUS Liberte Stent 50 statin 50 aortic regurgitation 50 mitral regurgitation 50 angiographic outcomes 50 lipid lowering therapy 50 sternal wound infections 50 torsades de pointes 50 grade glioma 50 intensive statin therapy 50 coronary interventions 50 Acute Myocardial Infarction AMI 50 ruptured aneurysms 50 MTWA 50 recurrent ischemic 50 biochemical recurrence 50 PSADT 50 proteinuria 50 anticoagulation therapy 50 doxorubicin docetaxel 50 NATRECOR R 50 HbA1c levels 50 nonsignificant 50 letrozole 50 severe exacerbations 50 recurrent DVT 50 warfarin 49 sustained ventricular tachycardia 49 Resolute DES 49 contralateral breast cancer 49 refractory ischemia 49 deferiprone 49 NATRECOR ® 49 arrhythmias 49 ventricular arrhythmia 49 UA NSTEMI 49 onset atrial fibrillation 49 rFVIIa 49 preterm delivery 49 lumiracoxib 49 bronchopulmonary dysplasia 49 ramipril 49 TAVR 49 macrovascular 49 patency 49 aneurysms 49 ventricular tachyarrhythmia 49 carotid endarterectomy CEA 49 ICD implants 49 Genous stent 49 salmeterol HFA MDI 49 hypoglycemic events 49 angina 49 Cypher Stent 49 Erythropoietic therapies may 49 teriflunomide 49 TAXUS Element Stent 49 disease progression 49 ACUITY trial 49 acute coronary 49 HES CEL 49 spontaneous preterm delivery 49 intussusception 49 celecoxib 49 troponin T 49 Rivaroxaban 49 Percutaneous Coronary Intervention 49 patients undergoing CABG 49 confirmed thrombotic cardiovascular 49 Taxus 49 lipid lowering drugs 49 de novo lesions 49 symptomatic atrial fibrillation 49 heartwire 49 sustained virologic response 49 chemoradiation 49 ventricular fibrillation VF 49 virological failure 49 pCR 49 segment elevation myocardial 49 asymptomatic AF 49 Atacand 49 nonvertebral fractures 49 cardiac resynchronization therapy 49 vessel renarrowing 49 resynchronization therapy 49 TRITON TIMI 49 severe aortic stenosis 49 coronary stenosis 49 segment binary restenosis 49 Acute Myocardial Infarction 49 octreotide LAR 49 microvascular disease 49 GIK infusion 49 acute ischemic stroke 49 defibrillator CRT D 49 ALCL 49 SCD HeFT 49 hypoglycaemia 49 coated stents 49 peri procedural 49 colectomy 49 endovascular repair 49 dose statin therapy 49 sinus rhythm 49 Coronary Stent 49 QT prolongation 49 coronary disease 49 ABSORB trial 49 postprocedure 49 idraparinux 49 fibrillation 49 suicidality 49 recanalization 49 tachyarrhythmias 49 laboratory abnormalities 49 rhythm disturbances 49 β blockers 49 treatment emergent adverse 49 severe neutropenia 49 severe psoriasis 49 stenting procedures 49 tardive dyskinesia 49 LQTS 49 rosuvastatin #mg 49 randomized trials 48 TAXUS IV 48 cangrelor 48 stroke myocardial infarction 48 subtrochanteric 48 acute PAO 48 percutaneous coronary interventions 48 hypercalcemia 48 stent thrombosis blood clots 48 antihypertensive drugs 48 Carotid Revascularization Endarterectomy vs. 48 angioplasty 48 nondiabetic patients 48 abacavir 48 statins 48 graft occlusion 48 postoperative delirium 48 myocardial reperfusion 48 revascularization procedure 48 Xience 48 ARIXTRA 48 distant metastases 48 levosimendan 48 muraglitazar 48 uncoated stent 48 morphometric vertebral fractures 48 annualized relapse 48 asthma exacerbations 48 AFib 48 thromboprophylaxis 48 sirolimus eluting 48 failure TVF 48 ischemic strokes 48 vasospasm 48 ventricular tachycardia VT 48 distal embolization 48 prespecified 48 undergoing angioplasty 48 tamponade 48 breast cancer recurrence 48 sirolimus 48 ACE inhibitor 48 bronchial thermoplasty 48 EXJADE 48 hemoglobin A1c levels 48 NEVO 48 undergoing coronary artery 48 hyperbilirubinemia 48 TAXUS Liberte stent 48 NSTEMI 48 invasive candidiasis 48 TAXUS TM 48 invasive coronary angiography 48 chlorambucil 48 tPA 48 surrogate endpoint 48 Thrombolysis 48 primary patency 48 non inferiority 48 cardiovascular disease CVD 48 reoperations 48 hypotension 48 PLAVIX 48 neurologic complications 48 MACE 48 clopidogrel Plavix 48 diameter stenosis 48 intracranial stenosis 48 Median survival 48 extrapyramidal symptoms 48 active comparator 48 anticoagulant therapy 48 hypersensitivity reactions 48 aldosterone antagonist 48 thrombotic 48 stent insertion 48 arterial thrombosis 48 pulmonary emboli 48 antiarrhythmic drug 48 decitabine 48 atherosclerotic disease 48 Myocardial Infarction 48 ticlopidine 48 invasive aspergillosis 48 Xience V 48 sustained virological response 48 vein clots 48 atheroma volume 48 rofecoxib 48 drug eluting coronary stents 48 subgroup analyzes 48 multivessel disease 48 thrombus aspiration 48 variceal bleeding 47 tecarfarin 47 subclinical hyperthyroidism 47 nadroparin 47 Edge STudy 47 Angiographic 47 chemoradiotherapy 47 Free Survival PFS 47 antiplatelet agent 47 carotid IMT 47 stent DES 47 Long Lesion 47 cardiovascular morbidity 47 advanced adenomas 47 antiepileptic drug 47 hs CRP 47 systolic hypertension 47 CMV infection 47 microbleeds 47 recurrent stroke 47 CHD CVD 47 SUDEP 47 variceal hemorrhage 47 ischemic complications 47 bypass graft CABG surgery 47 VADT 47 colorectal liver metastases 47 NSAID 47 bypass graft surgery 47 severe sepsis 47 postoperative pulmonary 47 valvular disease 47 perindopril 47 GP IIb IIIa inhibitors 47 nonvertebral fracture 47 necrotizing pancreatitis 47 fluvastatin 47 hypoglycemic episodes 47 neurodevelopmental impairment 47 LVSD 47 mycophenolate mofetil 47 plus dexamethasone 47 NT proBNP 47 hemorrhagic stroke 47 antithrombotic therapies 47 intima media thickness 47 acute decompensation 47 Toxicities 47 uncoated stents 47 bosentan 47 IIIa inhibitors 47 thrombogenic 47 binary restenosis rate 47 vandetanib 47 warfarin therapy 47 TACE 47 preterm birth 47 tumor shrinkage 47 transient ischemic attacks 47 radiographic progression 47 hematologic toxicity 47 TAXUS Express Atom Stent 47 trastuzumab 47 pneumonectomy 47 drug coated stents 47 radical nephrectomy 47 toxicities 47 Aortic Stenosis 47 perinatal mortality 47 oral anticoagulation 47 bivalirudin monotherapy 47 atorvastatin 47 postoperative AF 47 carotid artery disease 47 brain metastases 47 macrovascular disease 47 Dronedarone 47 death reinfarction 47 SYNTAX trial 47 apnea hypopnea index 47 asymptomatic carotid stenosis 47 Subgroup analyzes 47 XIENCE V stent 47 lymphadenectomy 47 TORISEL 47 bifurcation lesions 47 cystatin C 47 aneurysm rupture 47 oral allopurinol 47 acute STEMI 47 baseline HbA1c 47 ivabradine 47 venous thromboembolism VTE 47 TAXUS Liberté stent 47 deep venous thrombosis 47 salmeterol 47 HbA 1c levels 47 noncarriers 47 plus GP IIb 47 glycated hemoglobin levels 47 atypical fractures 47 nab paclitaxel 47 gadobutrol 47 ischemia 47 bloodstream infection 47 intracranial hemorrhage 47 SVR# 47 heparin induced thrombocytopenia 47 MADIT 47 recurrent venous thromboembolism 47 progression TTP 47 ADEs 47 syncopal 47 angiographic follow 47 postoperative bleeding 47 tamoxifen therapy 47 placebo controlled studies 47 FOLFOX 47 reperfusion therapy 47 FFR guided treatment 47 TAXUS ® 47 saphenous vein grafts 47 ENDEAVOR clinical 47 undergoing CABG 47 VTEs 47 hemorrhagic strokes 47 nephrotoxicity 47 ONJ 47 infarction 47 stents 47 NYHA Class III 47 zoledronic acid 47 TNF antagonist 47 HSCT 47 interferon beta therapy 47 timepoints 47 Thrombocytopenia 47 placebo controlled trials 47 spinal cord compression 47 echocardiographic 47 sunitinib 47 CTEPH 47 artery reclogging 47 Torsades de Pointes 47 MitraClip device 47 Kaplan Meier analysis 47 cardiopulmonary bypass 47 lacosamide 47 recurrent atrial fibrillation 47 oncologic outcomes 47 multicentre randomized 47 hypersensitivity reaction 47 platelet inhibition 47 persistent pulmonary hypertension 47 cerebral infarction 47 stroke transient ischemic 47 prospective multicenter randomized 46 Clinical Outcomes Utilizing Revascularization 46 seroconversion 46 Stenting 46 bisphosphonate therapy 46 lispro 46 atherothrombotic 46 hypoxemia 46 ExTRACT TIMI 46 femoral shaft fractures 46 cardioembolic stroke 46 posaconazole 46 adenoma recurrence 46 SPIRIT III 46 coronary lesions 46 elotuzumab 46 hematologic adverse 46 myocardial infarctions MIs 46 venous thromboembolic 46 peginterferon 46 lowering homocysteine 46 elective PCI 46 sepsis 46 cytoreductive surgery 46 CCyR 46 mg QD 46 ocular adverse 46 postoperative infections 46 imipenem 46 ruboxistaurin 46 Arrhythmias 46 pulmonary embolism PE 46 symptomatic aortic stenosis 46 ACTOS 46 serum cholesterol 46 tumor lysis syndrome 46 uterine rupture 46 ARB telmisartan 46 Acute MI 46 carotid stent 46 edoxaban 46 sudden cardiac 46 NGAL 46 Doxil ® 46 nonresponders 46 Taxus Liberte 46 catheter angiography 46 mg BID dose 46 dose cohorts 46 artery blockages 46 PICSO ® 46 wound dehiscence 46 tocilizumab 46 perfusion defects 46 endometrial carcinoma 46 renal toxicity 46 ischaemia 46 TAXUS VI 46 renarrowing 46 Contrast Induced Nephropathy CIN 46 aortic insufficiency 46 noninferior 46 ventricular dysfunction 46 atypical femur fractures 46 hydroxyurea 46 angina pectoris 46 thienopyridines 46 liver transplant recipients 46 implantable cardioverter defibrillator ICD 46 atypical antipsychotic drugs 46 irbesartan 46 oral anticoagulant 46 darapladib 46 complete cytogenetic response 46 subarachnoid haemorrhage 46 recurrent wheezing 46 cerebrovascular accident 46 Stent Thrombosis 46 infective endocarditis 46 risedronate 46 hypertensive patients 46 drug zotarolimus 46 randomized clinical trials 46 decompensated heart failure 46 carotid intima media 46 randomized multicenter 46 familial ALS 46 insulin glargine 46 febrile seizures 46 CYPHER 46 nocturnal hypoglycaemia 46 lamotrigine 46 A1c levels 46 relapsing multiple sclerosis 46 transcatheter closure 46 ventricular fibrillation 46 PRADAXA 46 DLTs 46 carotid stenting procedures 46 diastolic heart 46 fosamprenavir 46 noncardiac 46 ENDEAVOR IV 46 coronary heart 46 secondary endpoint 46 angiotensin converting enzyme inhibitors 46 serum phosphate 46 ALND 46 Thrombosis 46 distant metastasis 46 quetiapine 46 gastrointestinal perforations 46 tacrolimus 46 tapentadol ER 46 ECG abnormalities 46 ARVD 46 postoperative morbidity 46 Medtronic Endeavor stent 46 cardiac tamponade 46 transaminase elevations 46 systolic dysfunction 46 carotid artery stenting CAS 46 systemic corticosteroids 46 stent binary restenosis 46 EURIDIS 46 coronary 46 reperfusion 46 intracranial hemorrhage ICH 46 asymptomatic PAD 46 placebo controlled clinical 46 malperfusion 46 TAXUS Liberte 46 primary percutaneous coronary 46 postintervention 46 antiarrhythmic drugs 46 dabigatran 46 albuminuria 46 zotarolimus 46 CRESTOR #mg 46 transient ischemic attack 46 ischemic cardiovascular 46 Venous thromboembolism 46 antiplatelet drugs 46 FluCAM arm 46 apnea 46 Stenting Trial CREST 46 CK MB 46 secondary efficacy endpoints 46 prospective randomized 46 carotid surgery 46 cerebral ischemia 46 IV NSCLC 46 nonadherence 46 Innohep 46 vinorelbine 46 dose aspirin 46 workhorse lesions 46 parkinsonian symptoms 46 spontaneous preterm birth 46 Pulmonary embolism 46 coxibs 46 perioperative morbidity 46 coronary blockages 46 azacitidine 45 CETP inhibition 45 KIF6 carriers 45 Acute Coronary Syndromes ACS 45 ULORIC 45 Lp PLA2 45 occlusions 45 sotalol 45 indomethacin 45 plus gemcitabine 45 corrected QT interval 45 severe asthma exacerbations 45 ONGLYZA 45 prolongs survival 45 cytogenetic response 45 balloon angioplasty 45 variceal 45 Critical limb ischemia 45 riociguat 45 Acute myocardial infarction 45 graft patency 45 abnormal mammograms 45 lactic acidosis 45 symptomatic intracranial 45 medullary thyroid cancer 45 primary endpoint 45 Sirolimus Eluting Coronary Stent 45 afatinib 45 virological response 45 adjuvant chemotherapy 45 cardiovascular disease 45 APEX AMI trial 45 subclinical atherosclerosis 45 liver toxicity 45 curative resection 45 glimepiride 45 Hypotension 45 MERLIN TIMI 45 transfemoral 45 torsade de pointes 45 ibandronate 45 atherosclerotic progression 45 antibiotic prophylaxis 45 intravenous bisphosphonates 45 docetaxel chemotherapy 45 white matter hyperintensities 45 etanercept 45 coronary angiography 45 AIM HIGH 45 thrombocytopenic 45 delayed CINV 45 T2DM 45 proximal DVT 45 graft dysfunction 45 clazosentan 45 nonobstructive CAD 45 randomized controlled clinical trials 45 antiepileptic drugs 45 endometrial hyperplasia 45 Unstable angina 45 proliferative diabetic retinopathy 45 MI myocardial infarction 45 aneurysm ruptures 45 Hydroxyurea 45 Stent System 45 mitral stenosis 45 Angiomax 45 transcatheter aortic valve implantation 45 LEXIVA r 45 tamsulosin 45 HORIZONS AMI trial 45 nadolol 45 atrial tachyarrhythmias 45 cobiprostone 45 abatacept 45 certolizumab 45 eluting stents 45 recurrent miscarriage 45 TAXUS R 45 VIIBRYD 45 multicenter randomized 45 oral anticoagulation therapy 45 Kaplan Meier estimates 45 resistant hypertension 45 nondiabetics 45 QTc intervals 45 nicardipine 45 ACTEMRA TM 45 STEMIs 45 carotid artery stenosis 45 colorectal adenomas 45 aortic valve stenosis 45 ReoPro 45 Sirolimus eluting Coronary Stent 45 cilostazol 45 non metastatic osteosarcoma 45 candidemia 45 EVAR 45 EDSS scores 45 pulmonary thromboembolism 45 alteplase 45 reinterventions 45 superficial femoral 45 infusional 5-FU/LV 45 R0 resection 45 ACEI ARB 45 COPAXONE R 45 serum creatinine levels 45 acute myocardial infarctions 45 endometrial thickness 45 dose atorvastatin 45 circulating EPCs 45 uncontrolled asthma 45 nonfatal myocardial infarction MI 45 post surgical adhesions 45 saphenous vein graft 45 Brilinta 45 receiving prophylactic anticoagulation 45 gemcitabine 45 vancomycin 45 hyperglycemia 45 pretest probability 45 olanzapine 45 fibrinolysis 45 atherothrombosis 45 oxycodone CR 45 fatal arrhythmic 45 ARCALYST ® 45 cerebrovascular accidents 45 stented 45 thrombolytics 45 CLABSIs 45 placebo p 45 inhaled nitric oxide 45 artery stenosis 45 fibrinolytic therapy 45 empyema 45 PCIs 45 gastric ulcers 45 aortic rupture 45 Multicenter Automatic Defibrillator Implantation 45 hypoperfusion 45 icatibant 45 nonfasting triglycerides 45 dose regimens 45 MIRAPEX 45 rotigotine 45 AVANDIA 45 prospective randomized controlled 45 pheochromocytoma 45 thrombus formation 45 abdominal aortic aneurysms 45 intraoperative complications 45 patients undergoing percutaneous 45 Angioplasty 45 de ath 45 MGuard 45 QT interval 45 Dual Antiplatelet Therapy 45 dosing regimens 45 deep venous thromboses 45 coronary vessels 45 fluid overload 45 VLBW infants 45 aldosterone antagonists 45 valdecoxib 45 neoadjuvant 45 PROMUS 45 NEVO TM 45 left ventricular ejection 45 simvastatin ezetimibe 45 tachyarrhythmia 45 hypomagnesemia 45 osteoporotic fracture 45 dosage regimens 45 IVUS 45 CHD 45 carotid plaque 45 exacerbations 45 anastrozole 45 cardiovascular 45 anastomotic leak 45 elevated ALT 45 MS relapses 45 GORE VIABAHN Endoprosthesis 45 valproate 45 invasive breast cancer 45 cTnT levels